Knowledge of how intermolecular interactions of amyloidogenic proteins cause protein aggregation and how those interactions are affected by sequence and solution conditions is essential to our understanding of the onset of many degenerative diseases. Of particular interest is the aggregation of the amyloid-β (Aβ) peptide, linked to Alzheimer's disease, and the aggregation of the Sup35 yeast prion peptide, which resembles the mammalian prion protein (PrP) linked to spongiform encephalothopies. To facilitate the study of these important peptides, experimentalists have identified small peptide congeners of the full-length proteins that exhibit amyloidogenic behavior, including the KLVFFAE sequence of the Aβ protein, and the GNNQQNY sequence of Sup35. Reverse micelles provide an important environment for the study of protein folding and aggregation. In a reverse micelle, it is possible to observe the effects that confinement and water activity, believed to play a critical role in an in vivo cellular environment, have on protein folding, misfolding, and aggregation. We employed molecular dynamics simulations of reverse micelles as well as peptides encapsulated in reverse micelles in order to characterize the reverse micelle environment and identify fundamental principles that inform how sequence and solution environment influence protein aggregation. The peptides studied include the alanine-rich peptide AKA2 as well as the amyloidogenic KLVFFAE and GNNQQNY peptide fragments. The results of these studies suggest that substantial fluctuations in reverse micelle shape away from an idealized spherical geometry enables significant interaction between peptides and the surfactant interface. Analysis these results, including evaluation of water dynamics and calculated IR spectra of the amide I vibration of the peptides, indicate that our model of the reverse micelle is a robust one which captures essential features of this complex system. Moreover, our studies provide critical insight into the complex role played by a heterogeneous cellular environment in the earliest stages of protein aggregation and amyloid formation.

To survive, neurons and other eukaryotic cells must rapidly repair (seal) plasmalemmal damage. Such repair occurs by an accumulation of intracellular vesicles at or near the plasmalemmal disruption. Diacylglycerol (DAG)-dependent and cAMP-dependent proteins are involved in many vesicle trafficking pathways. Although recent studies have implicated the signaling molecule cAMP in sealing, no study has investigated how DAG and DAG-dependent proteins affect sealing and, whether pharmacological inhibition of such proteins could promote immediate repair of damaged mammalian axons. To this end, I investigated the role of DAG, protein kinase C (PKC) and other DAG-activated proteins in plasmalemmal sealing in B104 neurons in vitro and rat sciatic nerves in vivo. Using dye exclusion to assess Ca2+-dependent vesicle-mediated sealing of transected neurites of individually identifiable rat hippocampal B104 cells, I now report that, compared to non-treated controls, sealing probabilities and rates are increased by DAG and cAMP analogs that activate PKC and Munc13-1, and protein kinase A (PKA). Sealing is decreased by inhibiting DAG-activated novel protein kinase C isozymes η (nPKCη) and θ (nPKCθ) and, Munc13-1, the PKC effector myristoylated alanine rich PKC substrate (MARCKS) or phospholipase C (PLC). DAG-increased sealing is prevented by inhibiting MARCKS or PKA. Sealing probability is further decreased by simultaneously inhibiting nPKCη, nPKCθ and PKA. Extracellular Ca2+, DAG or cAMP analogs do not affect this decrease in sealing. I also report that applying inhibitors of nPKC and PKA to rat sciatic axons crush-severed in vivo under physiological calcium, do not promote immediate repair by polyethylene glycol (PEG), as assessed by compound action potential conduction and dye diffusion through crush sites. These and other data suggest that DAG increases sealing through MARCKS and that nPKCη, nPKCθ and PKA are all required to seal plasmalemmal damage in B104 neurons, and likely all eukaryotic cells. / text